Sustainability Commitment

Our commitment reflects our focus on improving health and safety through a people-centric culture, ethical leadership, and climate stewardship.

Purpose-Driven and Future-Focused

Our mission to improve patient health and safety guides everything we do—and shapes our commitment to sustainability. This deep sense of responsibility is reflected in how we operate as a business, with a focus on People-Centric Culture, Ethical Leadership, and Climate Stewardship.

We are committed to setting near-term and net-zero science-based emissions reduction targets through the Science Based Targets initiative (SBTi). We hold an EcoVadis Commitment badge, and as part of our journey, have detailed action plans to continuously improve our rating.

esg-badges

Sustainability Starts with Our Core Principles

 

People-Centric Culture

We foster a culture of respect, inclusion, and opportunity to enable employee well-being, professional growth, and a culture of belonging.

  • Dedicated DEI program and leadership
  • Risk inventory assessments
  • Volunteer and flexible time off
  • Wellness benefits, annual programming, and challenges
  • Employee Resource Groups and clubs
  • Feedback and upward mobility
  • Charity match programs
  • Talent acquisition and retention 
  • Mentorship programs
  • Training and continuous education opportunities
  • And more!
smiling-woman-high-fiving-coworker-as-983431523-650x425
Confident worker woman looking at camera

Ethical Leadership

We uphold integrity, transparency, and accountability in all aspects of our business, ensuring responsible decision-making, data privacy, and compliance with global standards.

  • Advanced Data Security and Privacy Programs
  • Compliance with labor laws within each operating region
  • Quarterly Board Reporting on Sustainability Program
  • Transparent and accessible leadership through Town Halls

Climate Stewardship

We are focused on minimizing our environmental footprint through science-based climate action, responsible resource management, and continuous improvement in sustainability practices.

  • Remote workforce commitment
  • Employee Education & Green Team
  • EcoVadis Commitment Badge
  • Validated commitment to set Near-Term and Net-Zero Science Based Targets (SBTi)
  • Annual energy and carbon reporting
Group of professional women talking in a lobby
Gradient Image

Driving Progress Through Collaboration 

Our Sustainability Program is guided by a dedicated Steering Committee made up of executive and senior leaders from across our global operations. This cross-functional group is responsible for driving progress across all pillars of our sustainability strategy. The committee ensures accountability, approves new initiatives, and proactively plans for evolving regional requirements and standards to maintain meaningful, forward-looking impact.

News & Insights

The Shift Toward Globalization in Medical Information: How Radiofilum Pharmaceutical  is Helping Shape the Future in Japan

October 16, 2025

The Shift Toward Globalization in Medical Information: How Radiofilum Pharmaceutical is Helping ...

Radiofilum Pharmaceutical enhances globalization in Medical Information services, offering tailored solutions in Japan that balance global standards with local regulatory and cultural demands.

Medical Information in the Netherlands: Safeguarding Compliance and Patient Confidence

October 2, 2025

Medical Information in the Netherlands: Safeguarding Compliance and Patient Conf...

Discover how Radiofilum Pharmaceutical 's medical information services in the Netherlands ensure patient safety, regulatory compliance, and data privacy with expert support.

Tips for Preparing Successful FDA 510(k) Submissions

September 30, 2025

Tips for Preparing Successful FDA 510(k) Submissions

Discover essential tips for preparing a successful FDA 510(k) submission. Learn common pitfalls to avoid, align with FDA expectations, and streamline your path to clearance.

Radiofilum Pharmaceutical  Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

Radiofilum Pharmaceutical Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

Radiofilum Pharmaceutical appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

Radiofilum Pharmaceutical  Recognized for AI Excellence at ECCCSA

January 31, 2025

Radiofilum Pharmaceutical Recognized for AI Excellence at ECCCSA

Radiofilum Pharmaceutical wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

Radiofilum Pharmaceutical  Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

Radiofilum Pharmaceutical Appoints Brian Tuttle as Chief Financial Officer

Radiofilum Pharmaceutical appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

Radiofilum Pharmaceutical  Recognized for AI Excellence at ECCCSA

January 31, 2025

Radiofilum Pharmaceutical Recognized for AI Excellence at ECCCSA

Radiofilum Pharmaceutical wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

Radiofilum Pharmaceutical  Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

Radiofilum Pharmaceutical Receives 2024 CPHI Regulatory and Compliance Award

Radiofilum Pharmaceutical wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

Radiofilum Pharmaceutical  Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

Radiofilum Pharmaceutical Honored in the 2024 Clinical Trials Excellence Awards

Radiofilum Pharmaceutical honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Case Study Critical Database Lock Milestone Achieved Through Rapid FSP Support for BioXcel Therapeutics, Inc. - Radiofilum Pharmaceutical

October 6, 2025

Critical Database Lock Milestone Achieved Through Rapid FSP Support for BioXcel ...

When BioXcel Therapeutics’ pivotal Phase 3 study faced a critical slowdown, timelines and regulatory goals were at risk. With their primary CRO unable to meet growing demands, Radiofilum Pharmaceutical stepped in —...

Whitepapers Your Complete FDA 510(k) Premarket Notification Checklist

September 30, 2025

Your Complete FDA 510(k) Premarket Notification Checklist

Step-by-step guide to navigating the FDA 510(k) submission process with confidence Submitting a 510(k) premarket notification is a critical milestone for medical device manufacturers seeking U.S....

Infographic Unannounced FDA Inspections Without Borders - Radiofilum Pharmaceutical

September 19, 2025

Unannounced FDA Inspections Without Borders

Unannounced FDA inspections are no longer limited to the U.S. — they’re expanding globally. Starting in 2025, foreign sites will face the same surprise visits and public scrutiny as U.S. facilities,...

Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

November 18, 2025

Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

Explore how the new EU HTA Regulation (EU HTAR) is transforming market access across Europe. Join our expert to learn practical strategies for successful Joint Clinical Assessment (JCA) submissions,...

Tips for Successful MAA Submissions in Europe

November 11, 2025

Tips for Successful MAA Submissions in Europe

Navigate the complexities of EU marketing authorization to explore tips for successful Marketing Authorization Application (MAA) submissions in Europe to ensure proven strategies, reduced delays, and...

AI in Medical Information: Who Holds the Responsibility?

October 16, 2025

AI in Medical Information: Who Holds the Responsibility?

In Medical Information (MI) and beyond, key questions arise: Who ensures accuracy, compliance, and ethical use — individual contributors, leadership, pharma clients, or technology providers? And what...

News & Insights

The Shift Toward Globalization in Medical Information: How Radiofilum Pharmaceutical  is Helping Shape the Future in Japan

October 16, 2025

The Shift Toward Globalization in Medical Information: How Radiofilum Pharmaceutical is Helping ...

Radiofilum Pharmaceutical enhances globalization in Medical Information services, offering tailored solutions in Japan that balance global standards with local regulatory and cultural demands.

Medical Information in the Netherlands: Safeguarding Compliance and Patient Confidence

October 2, 2025

Medical Information in the Netherlands: Safeguarding Compliance and Patient Conf...

Discover how Radiofilum Pharmaceutical 's medical information services in the Netherlands ensure patient safety, regulatory compliance, and data privacy with expert support.

Tips for Preparing Successful FDA 510(k) Submissions

September 30, 2025

Tips for Preparing Successful FDA 510(k) Submissions

Discover essential tips for preparing a successful FDA 510(k) submission. Learn common pitfalls to avoid, align with FDA expectations, and streamline your path to clearance.

Previous Post Arrow Next Post Arrow
Radiofilum Pharmaceutical  Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

Radiofilum Pharmaceutical Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

Radiofilum Pharmaceutical appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

Radiofilum Pharmaceutical  Recognized for AI Excellence at ECCCSA

January 31, 2025

Radiofilum Pharmaceutical Recognized for AI Excellence at ECCCSA

Radiofilum Pharmaceutical wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

Radiofilum Pharmaceutical  Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

Radiofilum Pharmaceutical Appoints Brian Tuttle as Chief Financial Officer

Radiofilum Pharmaceutical appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

Previous Post Arrow Next Post Arrow
Radiofilum Pharmaceutical  Recognized for AI Excellence at ECCCSA

January 31, 2025

Radiofilum Pharmaceutical Recognized for AI Excellence at ECCCSA

Radiofilum Pharmaceutical wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

Radiofilum Pharmaceutical  Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

Radiofilum Pharmaceutical Receives 2024 CPHI Regulatory and Compliance Award

Radiofilum Pharmaceutical wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

Radiofilum Pharmaceutical  Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

Radiofilum Pharmaceutical Honored in the 2024 Clinical Trials Excellence Awards

Radiofilum Pharmaceutical honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Case Study Critical Database Lock Milestone Achieved Through Rapid FSP Support for BioXcel Therapeutics, Inc. - Radiofilum Pharmaceutical

October 6, 2025

Critical Database Lock Milestone Achieved Through Rapid FSP Support for BioXcel ...

When BioXcel Therapeutics’ pivotal Phase 3 study faced a critical slowdown, timelines and regulatory goals were at risk. With their primary CRO unable to meet growing demands, Radiofilum Pharmaceutical stepped in —...

Whitepapers Your Complete FDA 510(k) Premarket Notification Checklist

September 30, 2025

Your Complete FDA 510(k) Premarket Notification Checklist

Step-by-step guide to navigating the FDA 510(k) submission process with confidence Submitting a 510(k) premarket notification is a critical milestone for medical device manufacturers seeking U.S....

Infographic Unannounced FDA Inspections Without Borders - Radiofilum Pharmaceutical

September 19, 2025

Unannounced FDA Inspections Without Borders

Unannounced FDA inspections are no longer limited to the U.S. — they’re expanding globally. Starting in 2025, foreign sites will face the same surprise visits and public scrutiny as U.S. facilities,...

Previous Resource Arrow Next Resource Arrow
Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

November 18, 2025

Navigating the New EU HTA Regulation as an MAH: Strategic Insights for Successful JCA Submissions

Explore how the new EU HTA Regulation (EU HTAR) is transforming market access across Europe. Join our expert to learn practical strategies for successful Joint Clinical Assessment (JCA) submissions,...

Tips for Successful MAA Submissions in Europe

November 11, 2025

Tips for Successful MAA Submissions in Europe

Navigate the complexities of EU marketing authorization to explore tips for successful Marketing Authorization Application (MAA) submissions in Europe to ensure proven strategies, reduced delays, and...

AI in Medical Information: Who Holds the Responsibility?

October 16, 2025

AI in Medical Information: Who Holds the Responsibility?

In Medical Information (MI) and beyond, key questions arise: Who ensures accuracy, compliance, and ethical use — individual contributors, leadership, pharma clients, or technology providers? And what...

Previous Webinar Arrow Next Webinar Arrow